Clinical Trials in Illinois

Showing 7061-7080 of 14,943 trials

Enzalutamide and Mifepristone in Treating Patients With Metastatic Hormone Resistant Prostate Cancer

NCT02012296

This partially randomized phase I/II trial studies the side effects and best dose of enzalutamide and mifepristone when given together and to see how well they work in treating patients with metastatic hormone resistant prostate cancer. Androgens can cause the growth of prostate cancer cells. Antihormone therapy, such as enzalutamide and mifepristone, may lessen the amount of androgens made by the body. It is not yet known whether enzalutamide is more effective with or without mifepristone in treating patients with prostate cancer.

Hormone-resistant Prostate CancerRecurrent Prostate CancerStage IV Prostate Cancer

University of Chicago88 participantsStarted Dec 2013

Chicago, Illinois, United States • Decatur, Illinois, United States • Evanston, Illinois, United States +1 more locations

COMPLETEDPhase 1/284 miles

BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma

NCT01034631

The purpose of this study is to determine whether BNC105P in combination with/following everolimus is effective in the treatment of progressive metastatic clear cell renal cell carcinoma following prior tyrosine kinase inhibitors.

Renal Cell Carcinoma

Hoosier Cancer Research Network154 participantsStarted Jan 2010

Muscle Shoals, Alabama, United States • Hot Springs, Arkansas, United States • Burbank, California, United States +105 more locations

Enzalutamide and Mifepristone in Treating Patients With Metastatic Hormone Resistant Prostate Cancer

BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma

Find Trials by Condition in Illinois

A Study of Taselisib + Fulvestrant Versus Placebo + Fulvestrant in Participants With Advanced or Metastatic Breast Cancer Who Have Disease Recurrence or Progression During or After Aromatase Inhibitor Therapy

Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD

A Safety and Efficacy Extension Study of a Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Patients With Hemophilia B

A Multi-centre Study to Assess the Safety, Tolerability, and Pharmacokinetics of Capivasertib (AZD5363) in Combination With Novel Agents in Patients With Metastatic Prostate Cancer

INGEVITY+ Active Fixation Pace/Sense Lead Clinical Study

An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Adults With Rheumatoid Arthritis

Evaluation of Implantable Tibial Neuromodulation (TITAN 1) Feasibility Study

Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin

Drug-Drug Interaction Study of HBI-3000 and Paroxetine in Healthy Adult Male and Female Subjects

A Study of APG-1252 in Patients With SCLC or Other Solid Tumors

A Study to Evaluate Androderm®'s Effect on Blood Pressure in Adult Hypogonodal Male Participants

Determining Disease Activity Biomarkers in Individuals With Polyarteritis Nodosa

Longitudinal Protocol for Granulomatosis With Polyangiitis (Wegener's) and Microscopic Polyangiitis

A Study of Epetraborole Tablets in Subjects With Degrees of Renal Function

Safety Study of Gene Modified Donor T-cells Following Partially Mismatched Stem Cell Transplant

ANAVEX2-73 for Treatment of Early Alzheimer's Disease

Treatment Intensity - Apraxia of Speech

An Exploratory Maintenance Trial of BI 655064 in Patients With Lupus Nephritis